Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lefitolimod maintenance in advanced colorectal carcinoma
NCT01208194Phase 2Completed
- Sponsor
- Mologen AG
- Start
- Jun 2010
- Primary completion
- Dec 2012
- Modality
- Antisense DNA, Prophylactic Vaccines, Small Interfering RNA (siRNA)
- Countries
- 6
01
Overview
A Phase 2 trial of lefitolimod in colorectal carcinoma (CRC), sponsored by Mologen AG. Started Jun 2010; status: completed.
02
Drugs
lefitolimod
03
Conditions
colorectal carcinoma (CRC)
Beyond the preview
Go deeper on NCT01208194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01208194.